Matches in SemOpenAlex for { <https://semopenalex.org/work/W1722158110> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W1722158110 endingPage "841" @default.
- W1722158110 startingPage "837" @default.
- W1722158110 abstract "Purpose: To evaluate the 2-year outcome, efficacy, and safety of intravitreal ranibizumab injections for myopic choroidal neovascularization (CNV). Methods: We retrospectively reviewed the medical records of 28 consecutive eyes that received intravitreal injections of ranibizumab for myopic CNV with a 24-month follow-up. Retreatment was performed as needed in eyes with persistent or recurrent CNV. Patient demographic data, best-corrected visual acuity (BCVA), CNV findings on fluorescent angiography, central macular thickness on optical coherence tomography, total number of treatments, and complications were recorded. Results: Mean baseline BCVA was 0.53±0.32 logMAR [Snellen equivalent (SE), 6/20], and improved significantly to 0.28±0.32 logMAR (SE, 6/11) at 1 year and 0.29±0.28 logMAR (SE, 6/12) at 2 years (both P<0.01, Wilcoxon signed-rank test). The average number of total injections over 2 years was 3.32 (SD 2.13). A mean of 2.82 injections were performed in the first year, and 0.50 in the second year. Twenty-three eyes (82.1%) had no need for treatment during the second year of follow-up. Mean improvement from the baseline was 2.57 Snellen lines (SD 2.35) at 1 year, and 2.29 lines (SD 2.69) at 2 years. At 2 years, 11 eyes (39.3%) showed a gain of at least 3 lines after treatment. No complications were noted after treatment. Conclusions: Intravitreal ranibizumab injection was safe and effective in treating myopic CNV, with visual improvement maintained over 2 years." @default.
- W1722158110 created "2016-06-24" @default.
- W1722158110 creator A5032318500 @default.
- W1722158110 creator A5054020049 @default.
- W1722158110 date "2014-12-01" @default.
- W1722158110 modified "2023-10-02" @default.
- W1722158110 title "Two-Year Outcome of Intravitreal Injections of Ranibizumab for Myopic Choroidal Neovascularization" @default.
- W1722158110 cites W110906275 @default.
- W1722158110 cites W1976795673 @default.
- W1722158110 cites W1985608223 @default.
- W1722158110 cites W2004361001 @default.
- W1722158110 cites W2007205785 @default.
- W1722158110 cites W2023526290 @default.
- W1722158110 cites W2028741508 @default.
- W1722158110 cites W2036634700 @default.
- W1722158110 cites W2045532670 @default.
- W1722158110 cites W2046924409 @default.
- W1722158110 cites W2047083844 @default.
- W1722158110 cites W2053445386 @default.
- W1722158110 cites W2063278513 @default.
- W1722158110 cites W2064140553 @default.
- W1722158110 cites W2072119754 @default.
- W1722158110 cites W2080591818 @default.
- W1722158110 cites W2082606620 @default.
- W1722158110 cites W2085039880 @default.
- W1722158110 cites W2085295554 @default.
- W1722158110 cites W2087703104 @default.
- W1722158110 cites W2092226078 @default.
- W1722158110 cites W2110226655 @default.
- W1722158110 cites W2168075687 @default.
- W1722158110 cites W233579014 @default.
- W1722158110 doi "https://doi.org/10.1089/jop.2014.0033" @default.
- W1722158110 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25162313" @default.
- W1722158110 hasPublicationYear "2014" @default.
- W1722158110 type Work @default.
- W1722158110 sameAs 1722158110 @default.
- W1722158110 citedByCount "13" @default.
- W1722158110 countsByYear W17221581102017 @default.
- W1722158110 countsByYear W17221581102018 @default.
- W1722158110 countsByYear W17221581102019 @default.
- W1722158110 countsByYear W17221581102020 @default.
- W1722158110 countsByYear W17221581102021 @default.
- W1722158110 countsByYear W17221581102023 @default.
- W1722158110 crossrefType "journal-article" @default.
- W1722158110 hasAuthorship W1722158110A5032318500 @default.
- W1722158110 hasAuthorship W1722158110A5054020049 @default.
- W1722158110 hasConcept C118487528 @default.
- W1722158110 hasConcept C141071460 @default.
- W1722158110 hasConcept C2776403814 @default.
- W1722158110 hasConcept C2776694085 @default.
- W1722158110 hasConcept C2777802072 @default.
- W1722158110 hasConcept C2778257484 @default.
- W1722158110 hasConcept C2781100027 @default.
- W1722158110 hasConcept C2781359195 @default.
- W1722158110 hasConcept C71924100 @default.
- W1722158110 hasConceptScore W1722158110C118487528 @default.
- W1722158110 hasConceptScore W1722158110C141071460 @default.
- W1722158110 hasConceptScore W1722158110C2776403814 @default.
- W1722158110 hasConceptScore W1722158110C2776694085 @default.
- W1722158110 hasConceptScore W1722158110C2777802072 @default.
- W1722158110 hasConceptScore W1722158110C2778257484 @default.
- W1722158110 hasConceptScore W1722158110C2781100027 @default.
- W1722158110 hasConceptScore W1722158110C2781359195 @default.
- W1722158110 hasConceptScore W1722158110C71924100 @default.
- W1722158110 hasIssue "10" @default.
- W1722158110 hasLocation W17221581101 @default.
- W1722158110 hasLocation W17221581102 @default.
- W1722158110 hasOpenAccess W1722158110 @default.
- W1722158110 hasPrimaryLocation W17221581101 @default.
- W1722158110 hasRelatedWork W1995044506 @default.
- W1722158110 hasRelatedWork W2042956061 @default.
- W1722158110 hasRelatedWork W2049577742 @default.
- W1722158110 hasRelatedWork W2054981704 @default.
- W1722158110 hasRelatedWork W2068871928 @default.
- W1722158110 hasRelatedWork W2227583243 @default.
- W1722158110 hasRelatedWork W2314067402 @default.
- W1722158110 hasRelatedWork W2396116581 @default.
- W1722158110 hasRelatedWork W2769959318 @default.
- W1722158110 hasRelatedWork W2599281049 @default.
- W1722158110 hasVolume "30" @default.
- W1722158110 isParatext "false" @default.
- W1722158110 isRetracted "false" @default.
- W1722158110 magId "1722158110" @default.
- W1722158110 workType "article" @default.